Ocular Pharmacokinetics of Moxifloxacin After Topical Treatment of Animals and Humans von Robertson, Stella M., Curtis, Michael A., Schlech, Barry A., Rusinko, Andrew, Owen, Geoffrey R., Dembinska, Olga, Liao, John, Dahlin, David C.

Volltext

In Vitro and In Vivo Potency of Moxifloxacin and Moxifloxacin Ophthalmic Solution 0.5%, A New Topical Fluoroquinolone von Stroman, David W., Dajcs, Joseph J., Cupp, Gale A., Schlech, Barry A.

Volltext

Overview of the Potency of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®) von Schlech, Barry A., Alfonso, Eduardo

Volltext

Future of Ophthalmic Anti-infective Therapy and the Role of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®) von Schlech, Barry A., Blondeau, Joseph

Volltext

Clinical and Epidemiological Advantages of Culturing Bacterial Keratitis von Wilhelmus, Kirk R, Schlech, Barry A

Volltext

Author's Response von Schlech, Barry

Volltext

Author's Response von Schlech, Barry

Volltext

Anatomy of a regimen: consideration of multipurpose solutions during non-compliant use von Rosenthal, Ruth A, Henry, Cindy L, Stone, Ralph P, Schlech, Barry A

Volltext

Efficacy of Myristamidopropyl Dimethylamine (Aldox®) Against Corneal Isolates of Acanthamoeba spp von SCHUSTER, FREDERICK L., BUCK, SALLY, ROSENTHAL, RUTH A., SCHLECH, BARRY A.

Volltext

Influence of Fluoroquinolone Susceptibility on the Therapeutic Response of Fluoroquinolone-Treated Bacterial Keratitis von Wilhelmus, Kirk R, Abshire, Robert L, Schlech, Barry A

Volltext

Topical antibacterial therapy for mycobacterial keratitis: Potential for surgical prophylaxis and treatment von Abshire, Robert, Cockrum, Paul, Crider, Julie, Schlech, Barry

Volltext

Contribution of regimen steps to disinfection of hydrophilic contact lenses von Rosenthal, Ruth A., Henry, Cindy L., Schlech, Barry A.

Volltext

The potency, ocular penetration, and safety of moxifloxacin (as VIGAMOX® solution), a topical ophthalmic fourth-generation fluoroquinolone von SCHLECH, Barry A

Volltext

In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone: The potency, ocular penetration, and safety of moxifloxacin (... von STROMAN, David W, DAJCS, Joseph J, CUPP, Gale A, SCHLECH, Barry A

Volltext

Poster 7 - Evaluation of a New Contact Lens Disinfectant Formulation for Disinfectant Efficacy von Rosenthal, Ruth, Bell, William, Schlech, Barry A.

Volltext

Poster 92 - Rigorous Microbiological Testing of a Multi-Dose Tear Replacement Formulation With No Preservatives von Rosenthal, Ruth, Buck, Sally, Schlech, Barry

Volltext

Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans: The potency, ocular penetration, and safety of moxifloxacin (as VIGAMOX® solution), a topical... von ROBERTSON, Stella M, CURTIS, Michael A, SCHLECH, Barry A, RUSINKO, Andrew, OWEN, Geoffrey R, DEMBINSKA, Olga, LIAO, John, DAHLIN, David C

Volltext

Poster 25 von Rosenthal, Ruth, Henry, Cindy, Schlech, Barry, Buck, Sally

Volltext

Poster 25: Continuous Efficacy by Novel Preservation System von Rosenthal, Ruth, Henry, Cindy, Schlech, Barry, Buck, Sally

Volltext

Ocular bioavailability of ciprofloxacin in sustained release formulations von KE, Tai-Lee, CAGLE, Gerald, SCHLECH, Barry, LORENZETTI, O. J, MATTERN, Janet

Volltext